| (AUD) | Jun 2025 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -64.30M | 51.91% |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, CU6.AX returned -32.1% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -26.6% |
| 1 year | -32.1% |
| 5 years | +73.4% |
| All-time high | $8.38 (Sep 2024) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in CU6.AX would be worth today ›No. Clarity Pharmaceuticals Ltd has not paid a dividend in the past 12 months.
Clarity Pharmaceuticals Ltd is part of the Healthcare sector.
Clarity Pharmaceuticals Ltd has a market cap of 925.24M AUD, based on the latest quote.
